Cassandra M. Pierre MD, MPH, MSc
Assistant Professor, Infectious Diseases
Medical Director of Public Health Programs , Infectious Diseases
771 Albany St | (617) 414-2894
Sections
Infectious Diseases
Biography
Residency training: Boston Medical Center
Fellowship training: Boston Medical Center
Dr. Cassandra Pierre is an Assistant Professor at the Chobanian and Avedisian School of Medicine, the Medical Director of Public Health Programs and the Associate Hospital Epidemiologist at Boston Medical Center and the Chair of the Diversity and Inclusion Council. Supported by state and local public health agencies, the Public Health Programs provide resources for HIV, HCV and STI prevention, linkage to care and management throughout the hospital. Her research is focused on infection prevention in vulnerable population (including the implementation of low-cost infection control interventions to reduce bacteremia among neonates in low-income settings) Her clinical interests include HIV management in special subpopulations (immigrants of color, pregnant women, transactional sex workers and people with substance use).
Other Positions
Education
MD, State University of New York at Buffalo
Global Health Management, MPH, Loma Linda University
English Literature, BA, Cornell University
Publications
Benson J, Pierre C, Joseph NT. Updates in the Management of HIV During Pregnancy. Clin Obstet Gynecol. 2024 Jul 02. PMID: 38946602.
Published on 4/24/2024Fletcher L, Burrowes S, Sabin LL, McCann N, Khan GK, Ruiz-Mercado G, Johnson S, Kimmel SD, Pierre C, Drainoni ML. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites. AIDS Patient Care STDS. 2024 May; 38(5):221-229. PMID: 38656905.
Published on 2/1/2024Stewart J, Ruiz-Mercado G, Sperring H, Pierre CM, Assoumou SA, Taylor JL. Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential Hospital. Open Forum Infect Dis. 2024 Mar; 11(3):ofae056. PMID: 38464490.
Published on 1/17/2024Assoumou SA, Bonilla HV, Vautour L, White C, Read Newcomb A, Kibbe D, Goldie J, Merrill A, Monahan M, Linas BP, Drainoni ML, Pierre CM, Graham R. A Communications Campaign to Build Confidence in Covid-19 Vaccines: The Boston Medical Center Experience. NEJM Catal Innov Care Deliv. 2024 Feb; 5(2). PMID: 38813133.
Published on 7/3/2023Nelson AL, Steiner J, Hanley D, Barlam TF, Drainoni ML, Burrowes SAB, Pierre CM. Revitalizing the infection prevention workforce with a fellowship program for underrepresented groups. Infect Control Hosp Epidemiol. 2023 Dec; 44(12):2050-2051. PMID: 37395044.
Published on 6/26/2023Egbe FN, Cowden C, Mwananyanda L, Pierre C, Mwansa J, Lukwesa Musyani C, Lyondo A, Kapasa ML, Machona S, Chilufya MM, Munanjala G, Coffin SE, Hamer DH, Bates MA. Etiology of Bacterial Sepsis and Isolate Resistance Patterns in Hospitalized Neonates in Zambia. Pediatr Infect Dis J. 2023 Oct 01; 42(10):921-926. PMID: 37364138.
Published on 3/6/2023Pepe DE, Mehrotra P, Bruno-Murtha LA, Colgrove R, Doron S, Duncan R, Ellison R, Haessler S, Hooper DC, Klompas M, Pierre CM, Sandora TJ, Shenoy ES, Wright SB. Use of expert consensus to develop a shared list of procedures with potential for aerosol generation during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e44. PMID: 36960085.
Published on 3/6/2023Pepe DE, Mehrotra P, Bruno-Murtha LA, Colgrove R, Doron S, Duncan R, Ellison R, Haessler S, Hooper DC, Klompas M, Pierre CM, Sandora TJ, Shenoy ES, Wright SB. Use of expert consensus to develop a shared list of procedures with potential for aerosol generation during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e44. PMID: 36960085.
Published on 1/10/2023Fletcher L, Burrowes SAB, Khan GK, Sabin L, Johnson S, Kimmel SD, Ruiz-Mercado G, Pierre C, Drainoni ML. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability. Harm Reduct J. 2023 Jan 10; 20(1):4. PMID: 36627679.
Published on 1/7/2023Stewart J, Bartkus M, Sperring H, Ruiz-Mercado G, Johnson S, Pierre C. Monkeypox Vaccination Strategy and Missed Opportunities in STI and HIV Prevention: An Urban Sexual Health Clinic's Experience During a Public Health Emergency. Open Forum Infect Dis. 2023 Jan; 10(1):ofad006. PMID: 36726550.
Media Mentions
Published on 6/7/2024
What to know about upcoming COVID-19 vaccines and the FLiRT variants
Published on 6/5/2024
Published on 5/31/2024
Local doctors push for more mpox vaccination as virus appears to be on the rise
Published on 5/30/2024
A potentially deadly tickborne disease is on the rise in the US
Published on 5/6/2024
5 Signs of Lyme Disease You Really Shouldn’t Ignore
Published on 3/25/2024
How Will New CDC COVID Guidelines Affect Workplaces?
Published on 3/12/2024
4 years after the COVID emergency, what the coronavirus means today
Published on 1/4/2024
Editorial: Be armed against triple COVID, flu, RSV viral threat
Published on 1/3/2024
This year’s COVID surge may just be starting. Here are four ways to protect yourself
Published on 1/3/2024
This year’s COVID surge may just be starting. Here are four ways to protect yourself.
View full list of 234 media mentions.